Michael Brouse Fallon MD FACP, FAASLD, AGAF
Hepatology & Liver Transplantation
Chair, Department of Medicine University of Arizona College of Medicine Phoenix
Join to View Full Profile
1441 N. 12th streetOffice 1082Phoenix, AZ 85006
Phone+1 602-839-5916
Dr. Fallon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Transplant Hepatology, 1989 - 1990- Yale-New Haven Medical CenterResidency, Internal Medicine, 1984 - 1987
University of Virginia School of MedicineClass of 1984
Certifications & Licensure
AZ State Medical License 2016 - 2026
AL State Medical License 1994 - 2025
TX State Medical License 2008 - 2024
CT State Medical License 1986 - 1995
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PathNet, Cerner Corporation, 2015-2016
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2015-2016
- CMS Meaningful Use Stage 1 Certification FirstNet (Clinical), Cerner Corporation, 2015-2016
Clinical Trials
- Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Start of enrollment: 2006 May 01
- Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome Start of enrollment: 2004 Jun 01
- The Effect of Sorafenib on Portal Pressure Start of enrollment: 2011 Aug 01
Publications & Presentations
PubMed
- 3 citationsInternational Liver Transplantation Society practice guideline update on portopulmonary hypertension.Hilary M DuBrock, Laurent Savale, Olivier Sitbon, Sarah Raevens, Steven M Kawut
Liver Transplantation. 2026-02-01 - Liver transplantation for hepatopulmonary syndrome: A systematic review and meta-analysis.Maïté Verstraeten, Mattice De Clercq, Hanne De Craemer, Xavier Verhelst, Sander Lefere
JHEP Reports. 2026-01-01 - 10 citationsGlobal burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021.Pojsakorn Danpanichkul, Kwanjit Duangsonk, Vincent L Chen, Preenapun Saokhieo, Disatorn Dejvajara
Hepatology. 2025-11-01
Press Mentions
Breaking the Cycle of Liver DamageSeptember 9th, 2025- Buffmire Lecture Sheds Light on Intimate Partner ViolenceOctober 17th, 2024
- ABRC Grant to Support Research of Lung Disease Linked to SmokingMarch 29th, 2023
Grant Support
- Novel Paxillin-FAK Inhibitors for the Treatment of Liver FibrosisFAKNOSTICS, LLC2024–2028
- Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndromeUNIVERSITY OF ARIZONA2023–2027
- Mediators Of Pulmonary Vasodilatation In Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Mediators Of Pulmonary Vasodilatation In Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2008
- Pentoxifylline For Cirrhotic Patients With Hepatopulmonary SyndromeNational Center For Research Resources2005–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
